论文信息 - Abstract 3598: A first-in-class tri-complex KRASG13C(ON) inhibitor validates therapeutic targeting of KRASG13Cand drives tumor regressions in preclinical models - 字舞流文

Abstract 3598: A first-in-class tri-complex KRASG13C(ON) inhibitor validates therapeutic targeting of KRASG13Cand drives tumor regressions in preclinical models

Mallika Singh | A. Gill | J. Knox | R. Nichols | L. Garrenton | K. Chou | C. Schulze | E. Koltun | Zhican Wang | Kyle J. Seamon | A. Bermingham | D. Wildes | J. Smith | James Cregg | Shaoling Li | Aidan Tomlinson | Yu Chi Yang